skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

Mayo Clinic proceedings, 2008, Vol.83 (2), p.181-194 [Peer Reviewed Journal]

Mayo Foundation for Medical Education and Research ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.4065/83.2.181

Full text available

Citations Cited by
  • Title:
    Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
  • Author: Tsiodras, Sotirios, MD, MSc, ScD ; Samonis, George, MD ; Boumpas, Dimitrios T., MD ; Kontoyiannis, Dimitrios P., MD, MSc, ScD
  • Subjects: Internal Medicine
  • Is Part Of: Mayo Clinic proceedings, 2008, Vol.83 (2), p.181-194
  • Description: Tumor necrosis factor α (TNF-α) blockade has emerged as a useful therapy for collagen vascular diseases or graft-vs-host disease. Fungal infections complicating such therapy have been reported sporadically. MEDLINE and PubMed databases (from January 1, 1966, to June 1, 2007) were searched for reports of invasive fungal infections (IFIs) associated with the 3 available anti-TNF-α agents, ie, infliximab, etanercept, and adalimumab. Of the 281 cases of IFI associated with TNF-α inhibition, 226 (80%) were associated with infliximab, 44 (16%) with etanercept, and 11 (4%) with adalimumab. Fungal infections associated with infliximab occurred a median of 55 days (interquartile range [IQR], 15-140 days) after initiation of therapy and 3 infusions of the medication (IQR, 2-5), whereas those associated with etanercept occurred a median of 144 days (IQR, 46-240 days) after initiation of therapy. The median age of patients was 58 years (IQR, 44-68 years), and 62% were male. Use of at least 1 other immunosuppressant medication, typically a systemic corticosteroid, was reported during the course of the fungal infection in 102 (98%) of the 104 patients for whom data were available. The most prevalent IFIs were histoplasmosis (n=84 [30%]), candidiasis (n=64 [23%]), and aspergillosis (n=64 [23%]). Pneumonia was the most common pattern of infection. Of the 90 (32%) of 281 cases for which outcome information was available, 29 fatalities (32%) were recorded. Tumor necrosis factor α blockade is associated with IFI across a range of host groups. A high index of suspicion in patients treated with TNF-α antagonists is recommended because the course of such infections can be serious or fulminant, and rapid access to health care should be provided. Surveillance of IFIs complicating TNF-α blockade and other biologic therapies is warranted through well-organized prospective patient registries.
  • Language: English
  • Identifier: ISSN: 0025-6196
    EISSN: 1942-5546
    DOI: 10.4065/83.2.181
  • Source: ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait